Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2025-12-30 @ 2:50 PM
Study NCT ID:
NCT04238195
Status:
COMPLETED
Last Update Posted:
2020-03-13
First Post:
2020-01-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects
Sponsor:
Spero Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-26
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-16
First Submit QC Date:
None
Study First Post Date:
2020-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-12
Last Update Post Date:
2020-03-13
Last Update Post Date Type:
ACTUAL